Health Condition 1: null- Pulmonary Arterial Hypertension
Conditions
Interventions
Intervention1: Routine treatment for Pulmonary Arterial Hypertension.: Patients will be treated as per the investigatorâ??s routine practice.
Control Intervention1: NOT APPLICABLE: NOT APPLICABLE
Sponsors
Cipla Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Written, signed, dated and ethics committee approved data sharing consent obtained from patients before performing any procedures. 2.Newly diagnosed or previously diagnosed patients with Group I PAH.
Exclusion criteria
Exclusion criteria: 1.Patients who meet the criteria for inclusion into Groups II, III, IV or V 2.Do not meet the required hemodynamic criteria for entry into the study when right heart catheterization data is available.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Characterize the demographics and clinical course of PAH patients and identify clinical predictors of short-term and long-term clinical outcomes.Timepoint: At the end of 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Assess the relationship between PAH medications and patient outcomesTimepoint: Throughout the study period;Evaluate and compare patient outcomesTimepoint: Throughout the study period;Incidence of any eventsTimepoint: Throughout the Study Period | — |
Countries
India
Contacts
Public ContactMr Rahul Namjoshi
Care Hospital
Outcome results
None listed